Caris Life Sciences Inc.

09/14/2026 | Press release | Distributed by Public on 09/14/2026 14:38

Regulation FD Disclosure (Form 8-K)

Item 7.01 Regulation FD Disclosure
Beginning on September 14, 2026, representatives of Caris Life Sciences, Inc. (the "Company") intend to use an investor presentation (the "Investor Presentation") in meetings with current and potential investors at the Morgan Stanley 24th Annual Global Healthcare Conference and from time to time at other investor conferences and meetings. The Company will post the Investor Presentation on its investor relations website at https://investor.carislifesciences.com. The website and presentation contents referenced herein are not incorporated into this Current Report on Form 8-K.
The information in this Item 7.01 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth in such filing.
Caris Life Sciences Inc. published this content on September 14, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on September 14, 2026 at 20:38 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]